Mutations induced in Haemophilus influenzae by transformation with nitrosoguanidine-treated DNA.
D002458:Cell Fractionation; D004269:DNA, Bacterial; D004352:Drug Resistance, Microbial; D004917:Erythromycin; D005978:Glutathione; D006146:Guanidines / Q000494:pharmacology*; D006193:Haemophilus influenzae; D007612:Kanamycin; D009153:Mutagens; D009154:Mutation / Q000187:drug effects*; D009603:Nitroso Compounds / Q000494:pharmacology*; D009604:Nitrosoguanidines / Q000494:pharmacology; D009675:Novobiocin; D013307:Streptomycin; D013997:Time Factors; D014170:Transformation, Genetic; D014466:Ultraviolet Rays; D014756:Viomycin
D004269:DNA, Bacterial; D006146:Guanidines; D009153:Mutagens; D009603:Nitroso Compounds; D009604:Nitrosoguanidines; D009675:Novobiocin; D007612:Kanamycin; D004917:Erythromycin; D005978:Glutathione; D013307:Streptomycin; D014756:Viomycin